Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRA | P10827 | 1/20 | 0.58 |
| ▸ | THRB | P10828 | 1/20 | 0.58 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.56 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.54 |
| ▸ | PPARA | Q07869 | 2/20 | 0.51 |
| ▸ | PPARG | P37231 | 1/20 | 0.49 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.46 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.46 |
| ▸ | BID | P55957 | 1/20 | 0.44 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.44 |
| ▸ | BAK1 | Q16611 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30432172 | 1.00 | THRA (0.58) | THRATHRBLIPGALOX5PTGS2 | |
| SCHEMBL3762716 | 1.00 | THRA (0.58) | THRATHRBLIPGALOX5PTGS2 | |
| SCHEMBL145217 | 1.00 | THRA (0.58) | THRATHRBLIPGALOX5PTGS2 | |
| SCHEMBL173283 | 1.00 | THRA (0.58) | THRATHRBLIPGALOX5PTGS2 | |
| SCHEMBL8052297 | 1.00 | THRA (0.58) | THRATHRBLIPGALOX5PTGS2 | |
| SCHEMBL941553 | 1.00 | THRA (0.58) | THRATHRBLIPGALOX5PTGS2 | |
| SCHEMBL93801 | 1.00 | THRA (0.58) | THRATHRBLIPGALOX5PTGS2 | |
| SCHEMBL9505410 | 1.00 | THRA (0.58) | THRATHRBLIPGALOX5PTGS2 | |
| SCHEMBL8444310 | 1.00 | THRA (0.58) | THRATHRBLIPGALOX5PTGS2 | |
| SCHEMBL5510952 | 1.00 | THRA (0.58) | THRATHRBLIPGALOX5PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250319047-A1 | ANTIMICROBIAL TREATMENT AND PREVENTION BY PERILLYL ALCOHOL AND DERIVATIVES | ZAYAS RIVERA JOSE (US) | 2025-10-16 | — | — | US | claimed |
| US-20220204968-A1 | LYSIS, BINDING AND/OR WASH REAGENT FOR ISOLATING AND/OR PURIFYING NUCLEIC ACIDS | QIAGEN GMBH (DE) | 2022-06-30 | — | — | US | claimed |
| US-12446576-B2 | Agrochemical formulation containing a sulfopolymer | EASTMAN CHEMICAL COMPANY (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250319047-A1 | ANTIMICROBIAL TREATMENT AND PREVENTION BY PERILLYL ALCOHOL AND DERIVATIVES | ZAYAS RIVERA JOSE (US) | 2025-10-16 | — | — | US | disclosed |
| US-20240349719-A1 | HIGHLY LOADED BROMOXYNIL FORMULATIONS | Adama Australia Pty Limited (AU) | 2024-10-24 | — | — | US | disclosed |
| CN-118368981-A | High-load bromoxynil formulation | 安道麦澳大利亚私人有限公司 | 2024-07-19 | — | — | CN | disclosed |
| US-20230329237-A1 | MUSA PLANTS, FIELDS CONTAINING SUCH PLANTS | TAMINCO BV (BE) | 2023-10-19 | — | — | US | disclosed |
| US-20230157296-A1 | METHODS OF REDUCING FUSARIUM CONTAMINATION | TAMINCO BV (BE) | 2023-05-25 | — | — | US | disclosed |
| US-20230147249-A1 | METHODS OF APPLYING A FUMIGANT TO REDUCE FUSARIUM CONTAMINATION | TAMINCO BV (BE) | 2023-05-11 | — | — | US | disclosed |
| US-20230143490-A1 | METHODS OF TREATING SOIL | TAMINCO BV (BE) | 2023-05-11 | — | — | US | disclosed |
| EP-4125361-A1 | MUSA PLANTS, FIELDS CONTAINING SUCH PLANTS | Taminco BV (BE) | 2023-02-08 | — | — | EP | disclosed |
| EP-4030903-A1 | HIGH LOAD FORMULATION CONTAINING A SULFOPOLYMER | Eastman Chemical Company (US) | 2022-07-27 | — | — | EP | disclosed |
| EP-4030901-A1 | SOLVENT DISPERSION FORMULATION CONTAINING A SULFOPOLYMER | Eastman Chemical Company (US) | 2022-07-27 | — | — | EP | disclosed |
| EP-4030912-A1 | WATER IMMISCIBLE SOLVENT-IN-WATER EMULSION FORMULATION CONTAINING A SULFOPOLYMER | Eastman Chemical Company (US) | 2022-07-27 | — | — | EP | disclosed |
| EP-4030906-A1 | AGROCHEMICAL FORMULATION CONTAINING A SULFOPOLYMER | Eastman Chemical Company (US) | 2022-07-27 | — | — | EP | disclosed |
| EP-4030909-A1 | DRIFT CONTROL ADJUVANT FORMULATION CONTAINING A SULFOPOLYMER | Eastman Chemical Company (US) | 2022-07-27 | — | — | EP | disclosed |
| EP-4030907-A1 | RAINFASTNESS ADJUVANT FORMULATION CONTAINING A SULFOPOLYMER | Eastman Chemical Company (US) | 2022-07-27 | — | — | EP | disclosed |
| EP-4030913-A1 | SPREADER FORMULATION CONTAINING A SULFOPOLYMER | Eastman Chemical Company (US) | 2022-07-27 | — | — | EP | disclosed |
| EP-4030905-A1 | AGRICULTURAL INERT PACKAGE FORMULATION CONTAINING A SULFOPOLYMER | Eastman Chemical Company (US) | 2022-07-27 | — | — | EP | disclosed |
| CN-114423286-A | Agrochemical formulations containing sulfopolymers | 伊士曼化工公司 | 2022-04-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230157296-A1 | METHODS OF REDUCING FUSARIUM CONTAMINATION | AS3MT, MTR, TOMM34 | THRA 1897/4885THRB 1489/4885LIPG 4163/4885 |
| US-12446576-B2 | Agrochemical formulation containing a sulfopolymer | ROS1, SQOR, RDX | THRA 4809/4885THRB 4773/4885LIPG 1848/4885 |
| US-20230143490-A1 | METHODS OF TREATING SOIL | DNMT1, AS3MT, MTR | THRA 3728/4885THRB 3563/4885LIPG 1181/4885 |
| US-20230147249-A1 | METHODS OF APPLYING A FUMIGANT TO REDUCE FUSARIUM CONTAMINATION | TMT1A, MTR, HTR4 | THRA 379/4885THRB 665/4885LIPG 4366/4885 |
| US-20230329237-A1 | MUSA PLANTS, FIELDS CONTAINING SUCH PLANTS | KDM4C, CHRM4, METTL3 | THRA 315/4885THRB 942/4885LIPG 4320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.